George Rosenkranz

George was a smart scientist.

He studied plants to make medicine.

He used plants from Mexico. These plants helped him make new drugs. He worked with a big team of scientists.

His team made medicine for many people. This medicine helped women stay healthy. It was a very big success.

George also loved card games. He was very good at a game called bridge. He even wrote books about it.

He lived to be 102 years old.

He was a very busy man.

George Rosenkranz was a famous scientist. He was born in Hungary in 1916.

Later, he moved to Mexico. He became a leader in steroid chemistry. This is the study of certain natural substances. He used plants from Mexico to make medicine.

George worked at a company called Syntex. He led a group of smart researchers. They worked hard to make new drugs. One big success was making cortisone. Cortisone is a medicine that helps with swelling. His team also made norethindrone. This was used in the first birth control pills.

George helped build schools for chemistry in Mexico. He wanted to train new scientists. He also loved the card game called bridge. He was a world-class player. He won many titles and wrote ten books about it.

George lived to be 102 years old. He won many awards for his work in science.

George Rosenkranz was a pioneering scientist who changed how we make medicine. He was born in Budapest, Hungary, in 1916.

His work focused on steroid chemistry, which is the study of special molecules called steroids. These molecules are very important for human health. Rosenkranz became a leader in using plants from Mexico to create these medicines. His discoveries helped turn the company Syntex into a huge force in biotechnology. He was a man who loved both deep science and complex games.

His scientific work followed a very careful, step-by-step path. First, he looked at Mexican plants like yams to find a substance called diosgenin. Then, his team worked to turn that plant material into useful steroids. In 1951, his team at Syntex worked in shifts to solve a hard problem. They wanted to find a way to make cortisone, a medicine that helps with swelling. Before they succeeded, making cortisone required 36 very difficult chemical steps using animal bile. By working together, Rosenkranz and his team found a better way to build these molecules.

Rosenkranz's journey to Mexico was shaped by world history. He studied in Switzerland under a mentor named Lavoslav Ružička. Because of the danger from Nazi sympathizers in Zurich, Rosenkranz and his colleagues decided to leave. He traveled through Cuba while waiting for a ship to Ecuador. During this time, the Japanese attacked Pearl Harbor and the United States entered World War II. This changed his plans, so he accepted an offer to work in Cuba. Eventually, his skills led him to Mexico City in 1945 to join Syntex.

Many important names and dates belong to his successful career. He worked with researchers like Carl Djerassi and Luis E. Miramontes. Together, they helped create norethindrone, a hormone used in early birth control pills. This medicine was approved by the FDA in 1957 as Norlutin. Rosenkranz also helped start the Instituto de Química to train new chemists in Mexico. He was a very busy man who wrote over 300 scientific articles. He even lived to be 102 years old, passing away in June 2019.

Outside of the lab, Rosenkranz was a master of the card game called bridge. He was a Grand Life Master with more than 13,000 masterpoints.

He won 12 major North American Bridge Championship titles. He even invented new ways to play, like the Romex bidding system. His life shows how one person can be great at many different things. He was a scientist, a teacher, and a world-class player all at once.

George Rosenkranz was a pioneering scientist who revolutionized the field of steroid chemistry. Born in Budapest, Hungary, on August 20, 1916, he spent his life studying how molecules could be built to improve human health. He is best known for his work in Mexico, where he used native plants as raw materials for medicine.

Through his leadership, he helped transform the Syntex corporation into a global leader in biotechnology. His work bridged the gap between natural plant life and modern pharmaceutical manufacturing.

Rosenkranz's scientific process focused on the synthesis of steroids, which are essential chemical compounds in the body. Before his breakthroughs, making certain medicines was incredibly difficult and inefficient. For example, producing the anti-inflammatory hormone cortisone required 36 different chemical transformations starting from animal bile acids. In 1951, Rosenkranz led a team at Syntex that worked in shifts to solve this problem. They successfully synthesized cortisone, beating reports from major institutions like Harvard by only a few weeks.

This success proved that complex hormones could be manufactured more effectively through chemical engineering.

The mechanism for his most famous work involved using Mexican plants to create hormones. The research began with the study of Mexican yams, which contain a substance called diosgenin. Rosenkranz and his team worked to convert this plant material into progesterone, a female sex hormone. Progesterone is vital for helping pregnant women avoid miscarriages and for treating infertility. Building on this, his team completed the synthesis of norethindrone, a powerful pregnancy inhibitor. This specific chemical process allowed for the creation of early combined oral contraceptive pills.

Rosenkranz's career was shaped by the major political shifts of the mid-20th century. He studied chemical engineering in Switzerland under the mentor Lavoslav Ružička. However, the presence of Nazi sympathizers in Zurich forced Rosenkranz and his colleagues to flee for safety. While waiting in Havana, Cuba, for a ship to Ecuador, the attack on Pearl Harbor occurred. This event brought the United States into World War II and altered his travel plans. He eventually moved to Mexico City in 1945 to join Syntex and replace researcher Russell Marker.

The impact of Rosenkranz's work can be seen in the massive growth of the pharmaceutical industry. His team at Syntex produced norethindrone, which was approved by the FDA in 1957 under the name Norlutin. Although a partnership with Parke-Davis faced delays due to social concerns, Syntex later partnered with Johnson & Johnson. This led to the introduction of the birth control pill Ortho-Novum. By 1964, the FDA had approved several versions of these oral contraceptives, including Norinyl and Norlestrin. These developments provided a massive infusion of capital into the Mexican steroid pharmaceutical industry.

Beyond the laboratory, Rosenkranz was a dedicated educator and community builder. Because Mexico lacked PhD programs in chemistry at the time, he recruited researchers from all over the world. He helped establish the Instituto de Química at the Universidad Nacional Autónoma de México. This institute became a flagship for ethnobotanical research, which is the study of how people use plants. He and his colleagues often spent their days at Syntex and their evenings teaching chemistry. He also played a role in starting the Institute for Molecular Biology in Palo Alto.

Rosenkranz was also a world-class expert in the card game known as duplicate bridge. He achieved the rank of American Contract Bridge League (ACBL) Grand Life Master. He earned more than 13,000 masterpoints and won 12 North American Bridge Championship titles.

He even contributed to the theory of the game by creating the Romex bidding system. He authored or co-authored over 10 books on bridge and invented specialized moves like the Rosenkranz double. His life was a unique combination of rigorous scientific inquiry and high-level strategic play.

Throughout his long life, Rosenkranz received numerous honors for his contributions to science and health. In 2012, he was awarded the Biotechnology Heritage Award for his innovations and public understanding. He also received the Winthrop-Sears Medal in 2004 and the Mexican National Prize in Pharmaceutical Sciences in 1994. Rosenkranz lived to be 102 years old, passing away on June 23, 2019. He left behind a legacy of over 300 scientific articles and more than 150 patents that continue to influence biotechnology today.